Annual CFO
$8.70 B
-$20.57 B-70.27%
31 December 2023
Summary:
Pfizer annual cash flow from operations is currently $8.70 billion, with the most recent change of -$20.57 billion (-70.27%) on 31 December 2023. During the last 3 years, it has fallen by -$5.70 billion (-39.60%). PFE annual CFO is now -73.30% below its all-time high of $32.58 billion, reached on 31 December 2021.PFE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$6.71 B
+$8.49 B+476.98%
30 September 2024
Summary:
Pfizer quarterly cash flow from operations is currently $6.71 billion, with the most recent change of +$8.49 billion (+476.98%) on 30 September 2024. Over the past year, it has increased by +$3.26 billion (+94.27%). PFE quarterly CFO is now -40.58% below its all-time high of $11.30 billion, reached on 01 June 2021.PFE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$11.26 B
+$3.26 B+40.70%
30 September 2024
Summary:
Pfizer TTM cash flow from operations is currently $11.26 billion, with the most recent change of +$3.26 billion (+40.70%) on 30 September 2024. Over the past year, it has dropped by -$779.00 million (-6.47%). PFE TTM CFO is now -67.43% below its all-time high of $34.58 billion, reached on 01 March 2022.PFE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -70.3% | +94.3% | -6.5% |
| 3 y3 years | -39.6% | -38.0% | -65.1% |
| 5 y5 years | -45.0% | +48.9% | -16.9% |
PFE Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -73.3% | at low | -38.0% | +477.0% | -67.4% | +40.7% |
| 5 y | 5 years | -73.3% | at low | -40.6% | +477.0% | -67.4% | +40.7% |
| alltime | all time | -73.3% | +1226.6% | -40.6% | +205.6% | -67.4% | +9956.3% |
Pfizer Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.71 B(-477.0%) | $11.26 B(+40.7%) |
| June 2024 | - | -$1.78 B(-263.4%) | $8.01 B(-6.7%) |
| Mar 2024 | - | $1.09 B(-79.2%) | $8.58 B(-1.4%) |
| Dec 2023 | $8.70 B(-70.3%) | $5.24 B(+51.6%) | $8.70 B(-27.8%) |
| Sept 2023 | - | $3.46 B(-386.1%) | $12.04 B(-17.3%) |
| June 2023 | - | -$1.21 B(-199.7%) | $14.56 B(-39.2%) |
| Mar 2023 | - | $1.21 B(-85.9%) | $23.94 B(-18.2%) |
| Dec 2022 | $29.27 B(-10.2%) | $8.58 B(+43.7%) | $29.27 B(+10.0%) |
| Sept 2022 | - | $5.97 B(-26.9%) | $26.60 B(-15.4%) |
| June 2022 | - | $8.17 B(+24.9%) | $31.45 B(-9.0%) |
| Mar 2022 | - | $6.54 B(+10.6%) | $34.58 B(+6.1%) |
| Dec 2021 | $32.58 B(+126.2%) | $5.91 B(-45.4%) | $32.58 B(+0.9%) |
| Sept 2021 | - | $10.83 B(-4.2%) | $32.29 B(+37.1%) |
| June 2021 | - | $11.30 B(+149.0%) | $23.55 B(+49.0%) |
| Mar 2021 | - | $4.54 B(-19.3%) | $15.81 B(+9.8%) |
| Dec 2020 | $14.40 B(+14.4%) | $5.63 B(+169.1%) | $14.40 B(+14.8%) |
| Sept 2020 | - | $2.09 B(-41.2%) | $12.55 B(-16.2%) |
| June 2020 | - | $3.56 B(+13.5%) | $14.97 B(+6.7%) |
| Mar 2020 | - | $3.13 B(-16.9%) | $14.02 B(+11.4%) |
| Dec 2019 | $12.59 B(-20.5%) | $3.77 B(-16.4%) | $12.59 B(-7.1%) |
| Sept 2019 | - | $4.51 B(+72.7%) | $13.56 B(-5.2%) |
| June 2019 | - | $2.61 B(+53.8%) | $14.31 B(-8.0%) |
| Mar 2019 | - | $1.70 B(-64.2%) | $15.54 B(-1.8%) |
| Dec 2018 | $15.83 B(-5.8%) | $4.74 B(-9.9%) | $15.83 B(-12.9%) |
| Sept 2018 | - | $5.26 B(+36.7%) | $18.18 B(+2.1%) |
| June 2018 | - | $3.85 B(+94.0%) | $17.81 B(+3.5%) |
| Mar 2018 | - | $1.98 B(-72.0%) | $17.20 B(+2.4%) |
| Dec 2017 | $16.80 B(+3.8%) | $7.09 B(+45.0%) | $16.80 B(+6.7%) |
| Sept 2017 | - | $4.89 B(+50.9%) | $15.75 B(+1.0%) |
| June 2017 | - | $3.24 B(+104.5%) | $15.60 B(-2.3%) |
| Mar 2017 | - | $1.58 B(-73.8%) | $15.97 B(-1.4%) |
| Dec 2016 | $16.19 B(+10.2%) | $6.04 B(+27.5%) | $16.19 B(+7.6%) |
| Sept 2016 | - | $4.74 B(+31.4%) | $15.05 B(-1.8%) |
| June 2016 | - | $3.61 B(+99.4%) | $15.33 B(-3.1%) |
| Mar 2016 | - | $1.81 B(-63.1%) | $15.82 B(+7.7%) |
| Dec 2015 | $14.69 B(-14.0%) | $4.90 B(-2.4%) | $14.69 B(-4.6%) |
| Sept 2015 | - | $5.02 B(+22.7%) | $15.39 B(+3.8%) |
| June 2015 | - | $4.09 B(+501.5%) | $14.83 B(+0.0%) |
| Mar 2015 | - | $680.00 M(-87.9%) | $14.83 B(-13.2%) |
| Dec 2014 | $17.08 B(-3.4%) | $5.60 B(+25.5%) | $17.08 B(-0.7%) |
| Sept 2014 | - | $4.46 B(+9.2%) | $17.21 B(-7.7%) |
| June 2014 | - | $4.09 B(+39.3%) | $18.65 B(+1.8%) |
| Mar 2014 | - | $2.94 B(-48.7%) | $18.32 B(+3.6%) |
| Dec 2013 | $17.68 B(+5.6%) | $5.72 B(-3.0%) | $17.68 B(+4.6%) |
| Sept 2013 | - | $5.90 B(+57.0%) | $16.91 B(+5.6%) |
| June 2013 | - | $3.76 B(+63.1%) | $16.01 B(-1.6%) |
| Mar 2013 | - | $2.30 B(-53.5%) | $16.27 B(-2.8%) |
| Dec 2012 | $16.75 B(-17.3%) | $4.95 B(-1.1%) | $16.75 B(-1.8%) |
| Sept 2012 | - | $5.00 B(+24.4%) | $17.06 B(+3.4%) |
| June 2012 | - | $4.02 B(+45.0%) | $16.50 B(-10.2%) |
| Mar 2012 | - | $2.77 B(-47.3%) | $18.37 B(-9.2%) |
| Dec 2011 | $20.24 B(+76.7%) | $5.26 B(+18.5%) | $20.24 B(-4.7%) |
| Sept 2011 | - | $4.44 B(-24.7%) | $21.24 B(-9.6%) |
| June 2011 | - | $5.90 B(+27.1%) | $23.48 B(+4.6%) |
| Mar 2011 | - | $4.64 B(-25.8%) | $22.46 B(+96.1%) |
| Dec 2010 | $11.45 B(-30.9%) | $6.26 B(-6.4%) | $11.45 B(+14.3%) |
| Sept 2010 | - | $6.68 B(+37.1%) | $10.02 B(+34.7%) |
| June 2010 | - | $4.87 B(-176.6%) | $7.44 B(+5.1%) |
| Mar 2010 | - | -$6.36 B(-231.8%) | $7.08 B(-57.3%) |
| Dec 2009 | $16.59 B(-9.1%) | $4.83 B(+17.7%) | $16.59 B(-6.5%) |
| Sept 2009 | - | $4.10 B(-9.1%) | $17.73 B(+0.8%) |
| June 2009 | - | $4.51 B(+43.4%) | $17.59 B(-2.9%) |
| Mar 2009 | - | $3.15 B(-47.3%) | $18.11 B(-0.7%) |
| Dec 2008 | $18.24 B(+36.6%) | $5.97 B(+51.1%) | $18.24 B(+13.8%) |
| Sept 2008 | - | $3.95 B(-21.6%) | $16.03 B(-4.3%) |
| June 2008 | - | $5.04 B(+54.1%) | $16.76 B(+9.0%) |
| Mar 2008 | - | $3.27 B(-13.2%) | $15.38 B(+15.2%) |
| Dec 2007 | $13.35 B | $3.77 B(-19.5%) | $13.35 B(-5.0%) |
| Sept 2007 | - | $4.68 B(+27.6%) | $14.06 B(+5.0%) |
| June 2007 | - | $3.67 B(+194.9%) | $13.40 B(-9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $1.24 B(-72.2%) | $14.88 B(-15.4%) |
| Dec 2006 | $17.59 B(+19.4%) | $4.48 B(+11.5%) | $17.59 B(-1.5%) |
| Sept 2006 | - | $4.01 B(-22.0%) | $17.86 B(+5.9%) |
| June 2006 | - | $5.14 B(+29.8%) | $16.85 B(+8.7%) |
| Mar 2006 | - | $3.96 B(-16.4%) | $15.50 B(+5.2%) |
| Dec 2005 | $14.73 B(-9.8%) | $4.74 B(+57.2%) | $14.73 B(-7.8%) |
| Sept 2005 | - | $3.01 B(-20.5%) | $15.99 B(-11.9%) |
| June 2005 | - | $3.79 B(+18.7%) | $18.15 B(+1.1%) |
| Mar 2005 | - | $3.19 B(-46.7%) | $17.95 B(+9.9%) |
| Dec 2004 | $16.34 B(+39.3%) | $5.99 B(+15.7%) | $16.34 B(+10.9%) |
| Sept 2004 | - | $5.18 B(+44.1%) | $14.73 B(+18.5%) |
| June 2004 | - | $3.59 B(+126.8%) | $12.43 B(+13.3%) |
| Mar 2004 | - | $1.58 B(-63.9%) | $10.97 B(-6.4%) |
| Dec 2003 | $11.73 B(+15.2%) | $4.38 B(+52.6%) | $11.73 B(+5.4%) |
| Sept 2003 | - | $2.87 B(+34.7%) | $11.13 B(+5.2%) |
| June 2003 | - | $2.13 B(-8.7%) | $10.57 B(-3.7%) |
| Mar 2003 | - | $2.34 B(-38.2%) | $10.98 B(+7.9%) |
| Dec 2002 | $10.18 B(+11.0%) | $3.78 B(+62.9%) | $10.18 B(+15.9%) |
| Sept 2002 | - | $2.32 B(-8.7%) | $8.78 B(-2.9%) |
| June 2002 | - | $2.54 B(+65.7%) | $9.04 B(+1.7%) |
| Mar 2002 | - | $1.53 B(-35.6%) | $8.89 B(-3.0%) |
| Dec 2001 | $9.17 B(+48.1%) | $2.38 B(-7.6%) | $9.17 B(-2.8%) |
| Sept 2001 | - | $2.58 B(+7.7%) | $9.44 B(+3.6%) |
| June 2001 | - | $2.40 B(+32.1%) | $9.11 B(+14.5%) |
| Mar 2001 | - | $1.81 B(-31.5%) | $7.96 B(+28.4%) |
| Dec 2000 | $6.20 B(+13.2%) | $2.65 B(+17.8%) | $6.20 B(+14.4%) |
| Sept 2000 | - | $2.25 B(+80.8%) | $5.41 B(+3.3%) |
| June 2000 | - | $1.24 B(+2292.3%) | $5.24 B(-7.2%) |
| Mar 2000 | - | $52.00 M(-97.2%) | $5.65 B(+3.2%) |
| Dec 1999 | $5.47 B(+5.6%) | $1.87 B(-10.1%) | $5.47 B(-24.5%) |
| Sept 1999 | - | $2.08 B(+25.7%) | $7.25 B(+21.2%) |
| June 1999 | - | $1.65 B(-1432.3%) | $5.98 B(+21.0%) |
| Mar 1999 | - | -$124.00 M(-103.4%) | $4.95 B(-4.5%) |
| Dec 1998 | $5.18 B(+236.4%) | $3.65 B(+350.8%) | $5.18 B(+164.5%) |
| Sept 1998 | - | $809.00 M(+31.8%) | $1.96 B(+23.4%) |
| June 1998 | - | $614.00 M(+453.2%) | $1.59 B(+14.7%) |
| Mar 1998 | - | $111.00 M(-73.9%) | $1.38 B(-10.1%) |
| Dec 1997 | $1.54 B(-21.5%) | $425.00 M(-3.0%) | $1.54 B(-12.7%) |
| Sept 1997 | - | $438.00 M(+6.8%) | $1.76 B(-7.9%) |
| June 1997 | - | $410.00 M(+53.6%) | $1.92 B(-4.6%) |
| Mar 1997 | - | $267.00 M(-58.9%) | $2.01 B(+2.3%) |
| Dec 1996 | $1.96 B(+7.7%) | $650.00 M(+10.4%) | $1.96 B(-0.2%) |
| Sept 1996 | - | $589.00 M(+17.3%) | $1.97 B(+9.5%) |
| June 1996 | - | $502.00 M(+127.1%) | $1.80 B(+20.9%) |
| Mar 1996 | - | $221.00 M(-66.2%) | $1.48 B(-18.5%) |
| Dec 1995 | $1.82 B(+22.4%) | $654.80 M(+56.8%) | $1.82 B(+10.5%) |
| Sept 1995 | - | $417.60 M(+118.4%) | $1.65 B(+0.8%) |
| June 1995 | - | $191.20 M(-65.7%) | $1.63 B(-9.2%) |
| Mar 1995 | - | $557.80 M(+15.9%) | $1.80 B(+21.0%) |
| Dec 1994 | $1.49 B(+17.9%) | $481.20 M(+19.0%) | $1.49 B(-11.8%) |
| Sept 1994 | - | $404.50 M(+13.1%) | $1.69 B(+5.2%) |
| June 1994 | - | $357.50 M(+45.7%) | $1.60 B(+8.6%) |
| Mar 1994 | - | $245.30 M(-63.9%) | $1.48 B(+16.9%) |
| Dec 1993 | $1.26 B(+56.5%) | $680.10 M(+111.5%) | $1.26 B(+34.9%) |
| Sept 1993 | - | $321.60 M(+39.9%) | $936.10 M(+7.2%) |
| June 1993 | - | $229.80 M(+629.5%) | $873.60 M(+7.3%) |
| Mar 1993 | - | $31.50 M(-91.1%) | $814.40 M(+0.9%) |
| Dec 1992 | $807.00 M(-4.8%) | $353.20 M(+36.3%) | $807.00 M(-1.8%) |
| Sept 1992 | - | $259.10 M(+51.9%) | $821.40 M(+11.9%) |
| June 1992 | - | $170.60 M(+607.9%) | $734.00 M(-7.6%) |
| Mar 1992 | - | $24.10 M(-93.4%) | $794.80 M(-6.2%) |
| Dec 1991 | $847.60 M(-1.5%) | $367.60 M(+114.1%) | $847.60 M(-4.1%) |
| Sept 1991 | - | $171.70 M(-25.8%) | $883.50 M(+5.2%) |
| June 1991 | - | $231.40 M(+200.9%) | $840.10 M(+1.8%) |
| Mar 1991 | - | $76.90 M(-80.9%) | $825.40 M(-4.1%) |
| Dec 1990 | $860.50 M(+31.2%) | $403.50 M(+214.5%) | $860.50 M(+88.3%) |
| Sept 1990 | - | $128.30 M(-40.8%) | $457.00 M(+39.0%) |
| June 1990 | - | $216.70 M(+93.5%) | $328.70 M(+193.5%) |
| Mar 1990 | - | $112.00 M | $112.00 M |
| Dec 1989 | $655.80 M | - | - |
FAQ
- What is Pfizer annual cash flow from operations?
- What is the all time high annual CFO for Pfizer?
- What is Pfizer annual CFO year-on-year change?
- What is Pfizer quarterly cash flow from operations?
- What is the all time high quarterly CFO for Pfizer?
- What is Pfizer quarterly CFO year-on-year change?
- What is Pfizer TTM cash flow from operations?
- What is the all time high TTM CFO for Pfizer?
- What is Pfizer TTM CFO year-on-year change?
What is Pfizer annual cash flow from operations?
The current annual CFO of PFE is $8.70 B
What is the all time high annual CFO for Pfizer?
Pfizer all-time high annual cash flow from operations is $32.58 B
What is Pfizer annual CFO year-on-year change?
Over the past year, PFE annual cash flow from operations has changed by -$20.57 B (-70.27%)
What is Pfizer quarterly cash flow from operations?
The current quarterly CFO of PFE is $6.71 B
What is the all time high quarterly CFO for Pfizer?
Pfizer all-time high quarterly cash flow from operations is $11.30 B
What is Pfizer quarterly CFO year-on-year change?
Over the past year, PFE quarterly cash flow from operations has changed by +$3.26 B (+94.27%)
What is Pfizer TTM cash flow from operations?
The current TTM CFO of PFE is $11.26 B
What is the all time high TTM CFO for Pfizer?
Pfizer all-time high TTM cash flow from operations is $34.58 B
What is Pfizer TTM CFO year-on-year change?
Over the past year, PFE TTM cash flow from operations has changed by -$779.00 M (-6.47%)